GeneralNeutralBlockonomi · 5h ago5/10
📰
Eli Lilly Finalizes $7.8B Centessa (CNTA) Acquisition with 183% Stock Rally
Eli Lilly completed its $7.8 billion acquisition of Centessa Pharmaceuticals at $38 per share, with the biotech company's stock experiencing a 183% surge before delisting. The transaction marks a significant consolidation in the pharmaceutical sector and represents a major exit event for Centessa shareholders.